| Ytd | 16.38% | |
| 1y | -62.50% |
| Open | 2.70 | Prev Close | 2.92 | Low | 2.70 | High | 2.70 | Mkt Cap | 6.91M |
| Vol | 1.70K | Avg Vol | 1.98M | EPS | -0.20 | P/E | -14.60 | Forward P/E | N/A |
| Beta | 1.45 | Short Ratio | 3.35 | Inst. Own | 1.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.59 | 200-d Avg | 3.24 | 1yr Est | 0.00 |
Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
expands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Com
RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:
US stocks lower, Dow falls 100 points. Energy shares up 1%, communication services down 0.7%. Brinke
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TAS
RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE N
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and po
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and po
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and pow
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE
JERUSALEM, Sept. 20, 2021 /PRNewswire/ -- Dr. Morris C.
The stock price of XTL Biopharmaceuticals (NASDAQ: XTLB) has increased by over 100% pre-market. This
During Wednesday's morning trading, 254 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Tuesday